Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
ID: 349478Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349478

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-238.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life," aimed at promoting research that explores the connection between social disconnection, including loneliness, and suicidal thoughts and behaviors among older adults. The initiative seeks applications for R01 grants to identify neurobiological and environmental mechanisms that increase suicide risk due to social isolation, as well as to develop interventions and service delivery models to enhance social connections in late life. This funding is particularly significant given the rising suicide rates among older adults and the need to improve health equity in mental health contexts. Interested applicants, including various educational institutions and community organizations, must submit their proposals by June 5, 2026, and can find additional information and guidelines at the NIH grants website or contact grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-238-Full-Announcement.html
    PAR-23-238.html
    The Department of Health and Human Services, through the National Institutes of Health, has issued a Notice of Funding Opportunity (NOFO) titled "Social Disconnection and Suicide Risk in Late Life." The purpose is to promote research linking social disconnection, including loneliness, to suicidal thoughts and behaviors in older adults. The focus is on identifying mechanisms whereby social disconnection increases suicide risk, while social integration might provide protection, encompassing neurobiological, behavioral, and environmental levels of analysis. The NOFO encourages applications for R01 grants, with a companion R21 opportunity for high-risk projects lacking preliminary data. Key dates include application submission deadlines beginning October 5, 2023, through June 5, 2026. Eligible applicants include various higher education institutions, nonprofits, and government entities. The funding aims to address the critical rise in suicide rates among older adults and improve health equity in the context of social connections and mental health. All applications must adhere to specific guidelines, and proposals will undergo thorough peer review based on significance, investigator expertise, innovation, research approach, and environment. This initiative highlights the urgent need for targeted research to better understand and address late-life suicide risks.
    Similar Opportunities
    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)" aimed at stimulating research on the relationship between social disconnection, including both objective social isolation and perceived loneliness, and suicide risk among older adults. The initiative seeks applications for research projects that explore neurobiological and environmental mechanisms contributing to suicidal thoughts and behaviors in late life, with a focus on developing and testing interventions to enhance social connection and prevent suicide. This funding opportunity is particularly significant given the rising suicide rates in the aging population, exacerbated by social isolation, and encourages innovative research methodologies to address these mental health challenges. Interested applicants can find more details and submit their proposals by the closing date of September 7, 2026, and should direct inquiries to grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-238.html.
    Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life," aimed at exploring the relationship between social isolation and suicide risk among older adults. This initiative encourages research projects that investigate neurobiological and environmental mechanisms linking social disconnection and loneliness to increased suicidal thoughts and behaviors, with a focus on developing interventions to enhance social connections and prevent suicide in late life. Given the rising suicide rates in this demographic, the NIH emphasizes the urgent need for targeted research, particularly addressing disparities across various populations. Selected projects may receive funding of up to $275,000 over two years, with applications accepted starting January 2025 and a submission deadline of September 7, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-066.html.
    Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)" aimed at supporting research on the relationship between social disconnection and suicide risk among older adults. This initiative seeks innovative projects that explore neurobiological, behavioral, and environmental mechanisms influencing social isolation and its impact on suicidal thoughts and behaviors, with an emphasis on promoting health equity and developing interventions to enhance social support. The grant provides a maximum funding amount of $275,000 over a two-year period, with applications due by September 7, 2026. Interested applicants can find more information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Research Opportunities in Crisis Response Services for Suicide Prevention," aimed at supporting exploratory research into the effectiveness and implementation of crisis response services designed to prevent suicides. This initiative seeks to evaluate the impact of state and local policies on crisis service outcomes, focusing on real-world applications that consider various factors such as clinical presentations, geographic settings, cultural considerations, and health disparities. The total funding available is $2 million across fiscal years 2025-2026, with individual project budgets capped at $225,000 per year for a maximum of three years. Interested applicants can find more information and submission guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov. The application deadline is June 2, 2025.
    Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)" aimed at advancing research on crisis response services related to suicide prevention. This initiative seeks proposals that examine the impact of state and local policies on the implementation and outcomes of crisis response services, particularly in the context of the 988 rollout, while considering various demographic and psychosocial factors. The program emphasizes the importance of real-world research settings and encourages community collaborations to enhance the practical application of findings. Up to $2,000,000 is available for this initiative, with the intention of awarding approximately 3-5 grants annually over a potential project period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application window opening on September 1, 2024, and the close date set for June 2, 2025.
    Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings," aimed at evaluating the effectiveness of interventions that promote the safe storage of potentially lethal means, such as firearms and medications, for individuals at increased risk of suicide. This initiative, through the National Institute of Mental Health (NIMH), seeks applications for R34 Planning Grants to conduct pilot effectiveness research on lethal means safety strategies, which have shown promise in reducing suicide attempts but require further evidence in healthcare and community settings. The total funding available is $1.5 million, with up to six grants awarded, each with a maximum budget of $450,000 over three years. Interested applicants must submit their proposals by June 15, 2024, for an initial review in November 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life," aimed at advancing research on the emergence and trajectory of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to identify biological, psychosocial, and environmental mechanisms affecting this population to develop effective prevention and treatment strategies, addressing a critical gap in mental health research. The funding utilizes the R01 grant mechanism, with applications accepted starting January 5, 2025, and a project period of up to five years. Eligible applicants include a wide range of institutions and organizations, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov. The application deadline is September 7, 2026.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)" aimed at advancing research on schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to explore the mechanisms, trajectories, and outcomes of these disorders, with a focus on identifying targets for prevention and treatment interventions, particularly emphasizing the inclusion of diverse research teams and individuals with lived experience. The funding is available through the R01 grant mechanism, with applications due by September 7, 2026, and interested applicants are encouraged to adhere strictly to the application guidelines and contribute data to the National Institute of Mental Health Data Archive. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-023.html.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life" (PAR-24-026), aimed at advancing research on the onset and progression of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to promote high-risk exploratory and developmental projects that investigate neurobiological, psychosocial, and environmental factors contributing to these disorders, with a particular emphasis on addressing health disparities among minority and aging populations. The program offers a maximum funding amount of $275,000 over two years, with applications due by November 16, 2023, for the initial cycle. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research on schizophrenia and related disorders in individuals aged 35 and older, through the R21 grant mechanism. This initiative aims to enhance understanding of the onset, trajectory, and outcomes of these disorders in mid- to late-life, encouraging innovative studies that identify biological, behavioral, and environmental risk factors, as well as potential interventions. The funding, which can reach up to $275,000 over a maximum of two years, is crucial for addressing health disparities faced by older adults with these disorders and promoting novel solutions for their care. Applications are due between January 2025 and October 2026, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.